Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureSumaira Qayoom, Namrata P. Awasthi
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Leptomeningeal disease and breast cancer: The importance of tumor subtype
10.1007/s10549-014-3054-z · 2014
Leptomeningeal metastases in glioma: The memorial sloan kettering cancer center experience
10.1212/wnl.0000000000007529 · 2019
Meningeal carcinomatosis in small cell carcinoma of the lung
10.1016/0002-9343(81)90254-0 · 1981
Diagnostic accuracy of cerebrospinal fluid (CSF) cytology in metastatic tumors: An analysis of consecutive CSF samples
10.4132/koreanjpathol.2013.47.6.563 · 2013
Evaluating circulating tumor DNA from the cerebrospinal fluid of patients with melanoma and leptomeningeal disease
10.1093/jnen/nly046 · 2018
Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma
10.1002/cncr.11436 · 2003
Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis
10.1016/j.cell.2017.02.025 · 2017
Cerebrospinal fluid pleocytosis : Pitfalls and benefits of combined analysis using cytomorphology and flow cytometry
10.1002/cncy.20127 · 2011
Leptomeningeal metastasis: The role of cerebrospinal fluid diagnostics
10.3389/fneur.2019.00839 · 2019
CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies
10.1212/01.wnl.0000261909.28915.83 · 2007
Cerebrospinal fluid from patients with hematopoietic neoplasms: The need for an integrated approach
10.1016/j.jasc.2017.06.004 · 2017
Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases
2020
Leptomeningeal metastasis
10.1097/cco.0b013e32833de986 · 2010
Pitfalls in cerebrospinal fluid analysis: A case report of carcinomatous meningitis mimicking infective causes
10.1016/j.jfma.2019.02.004 · 2019
Flow cytometric immunophenotyping for hematologic neoplasms
10.1182/blood-2007-11-120535 · 2008
Leptomeningeal metastases in high-grade adult glioma: Development, diagnosis, management, and outcomes in a series of 34 patients
10.3389/fneur.2014.00220 · 2014
Tumor invasion after treatment of glioblastoma with bevacizumab: Radiographic and pathologic correlation in humans and mice
10.1093/neuonc/nop027 · 2010
High sensitivity of flow cytometry improves detection of occult leptomeningeal disease in acute lymphoblastic leukemia and lymphoblastic lymphoma
10.1007/s00277-014-2080-6 · 2014
P14.04 Characteristics of cerebrospinal fluid in hematologic malignancy
10.1093/neuonc/nox036.391 · 2017
Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases
10.1007/s11060-022-03949-1 · 2022
Spatial and temporal variation of routine parameters: Pitfalls in the cerebrospinal fluid analysis in central nervous system infections
10.1186/s12974-022-02538-3 · 2022
Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis
10.1007/s00415-011-6221-8 · 2012
Cerebrospinal fluid abnormalities in meningeosis neoplastica: A retrospective 12-year analysis
10.1186/s12987-017-0057-2 · 2017
Cerebrospinal fluid findings in patients with hematologic neoplasms and meningeal infiltration
10.1007/s13760-020-01397-0 · 2021
Leptomeningeal metastasis of primary central nervous system (CNS) neoplasms
10.1007/0-387-24199-x_5 · 2005
The anatomic basis of leptomeningeal metastasis
10.1084/jem.20212121 · 2024
MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents
10.1016/j.mri.2004.01.050 · 2004
Cerebrospinal fluid cytology in patients with cancer: Minimizing false- negative results
10.1002/(sici)1097-0142(19980215)82:4<733::aid-cncr17>3.0.co;2-z · 1998
Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: A children's oncology group report
10.1182/blood.2022018653 · 2023
Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: Diagnostic and prognostic value
10.1038/sj.bjc.6601953 · 2004
Leptomeningeal metastasis: Survival and prognostic factors in 155 patients
10.1016/j.jns.2004.05.008 · 2004
Cerebrospinal fluid: A unique source of circulating tumor DNA with broad clinical applications
10.1016/j.tranon.2023.101688 · 2023
Tumor marker test in cerebrospinal fluid for leptomeningeal metastasis diagnosis and response assessment in non-small-cell lung cancer
10.1111/ene.70245 · 2025
Leptomeningeal metastasis: Clinical experience of 519 cases
10.1016/j.ejca.2015.12.021 · 2016
Diagnostic value of cerebrospinal fluid level of carcinoembryonic antigen in patients with leptomeningeal carcinomatous metastasis
10.3988/jcn.2010.6.1.33 · 2010
Added prognostic value of circulating tumor cell numbers in CSF of patients with leptomeningeal metastasis from epithelial tumors
2025
Contamination of cerebrospinal fluid by vertebral bone-marrow cells during lumbar puncture
10.1056/nejm198303243081206 · 1983
Brain metastases and leptomeningeal disease
10.1212/con.0000000000001354 · 2023
Comparison of the diagnostic significance of cerebrospinal fluid metagenomic next-generation sequencing copy number variation analysis and cytology in leptomeningeal malignancy
10.1186/s12883-024-03655-7 · 2024
Leptomeningeal metastasis: Challenges in diagnosis and treatment
10.2174/157339411797642597 · 2011
Leptomeningeal metastasis in gliomas: Clinical characteristics and risk factors
10.3340/jkns.2022.0166 · doi-reference
Central nervous system prophylaxis and treatment in acute leukemias
10.1007/s11864-022-01032-5 · doi-reference
Diagnosis of leptomeningeal metastasis in women with breast cancer through identification of tumor cells in cerebrospinal fluid using the CNSide™ assay
10.1016/j.clbc.2021.11.002 · doi-reference
Leptomeningeal metastases: New opportunities in the modern era
10.1007/s13311-022-01261-4 · doi-reference
Detection of cancer cells in the cerebrospinal fluid: Current methods and future directions
10.1186/2045-8118-8-14 · doi-reference
D- and L-lactate in rabbit and human bacterial meningitis
10.1080/00365540110076732 · doi-reference
Humoral CSF parameters in the differential diagnosis of hematologic CNS neoplasia
10.1111/j.1600-0404.1992.tb05053.x · doi-reference
Cerebrospinal fluid data. 1. Interpretation in intracranial hemorrhage and meningitis
10.1080/00325481.1980.11715571 · doi-reference
Brain stem and spinal metastases of supratentorial glioblastoma multiforme: A clinical series
10.1227/00006123-199010000-00002 · doi-reference
A systematic review of cases of meningitis in the absence of cerebrospinal fluid pleocytosis on lumbar puncture
10.1186/s12879-019-4204-z · doi-reference
Cerebrospinal fluid cytology: A highly diagnostic method for the detection of diseases of the central nervous system
10.1515/labmed-2016-0044 · doi-reference
Early detection of leptomeningeal metastasis by PCR examination of tumor-derived K-ras DNA in cerebrospinal fluid
10.1093/clinchem/46.1.132 · doi-reference
CSF cell-free DNA EGFR testing using DdPCR holds promise over conventional modalities for diagnosing leptomeningeal involvement in patients with non-small cell lung cancer
10.1016/j.lungcan.2020.07.034 · doi-reference
Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis
10.1093/neuonc/nor172 · doi-reference
Treatment of higher risk acute lymphoblastic leukemia in young people (CCG-1961), long-term follow-up: A report from the children's oncology group
10.1038/s41375-019-0422-z · doi-reference
Central nervous system involvement in haematolymphoid malignancies – Role of cerebrospinal fluid cytology in the diagnosis
10.4103/jdap.jdap_18_25 · doi-reference
Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy
10.1002/ijc.30147 · doi-reference
Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care
10.1111/pcmr.13116 · doi-reference
Meningeal carcinomatosis: Origin of local IgG production in the CSF
10.1212/wnl.38.3.413 · doi-reference
Leptomeningeal disease in oligodendroglial tumors: A population-based study
10.1007/s11060-011-0551-3 · doi-reference
Non-linear ventriculo – Lumbar protein gradients validate the diffusion-flow model for the blood-CSF barrier
10.1016/j.cca.2020.12.002 · doi-reference
Cytological features of cutaneous granular cell tumor: A brief report
10.4103/joc.joc_31_19 · doi-reference
Breast cancer leptomeningeal metastasis: Propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival
10.1007/s12032-012-0408-4 · doi-reference
Leptomeningeal metastasis: A review of the pathophysiology, diagnostic methodology, and therapeutic landscape
10.3390/curroncol30060442 · doi-reference
Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors
10.1212/wnl.0b013e31828f183f · doi-reference
Comments on listeriosis of the CNS zur listeriose des zentralnervensystems
10.1055/s-2007-1001204 · doi-reference
Cytological features of melanoma in exfoliative fluid specimens
10.1136/jcp.2009.065599 · doi-reference
Pediatric-inspired protocols in adult acute lymphoblastic leukemia: Are the results bearing fruit?
10.1182/hematology.2019000009 · doi-reference
Correction: Initial and follow-up evaluations on cerebrospinal fluid involvement by hematologic malignancy
10.1007/s12308-023-00553-8 · doi-reference
Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome
10.3324/haematol.2016.147728 · doi-reference
Leptomeningeal carcinomatosis in early gastric cancer: A case report and literature review
10.3390/healthcare12121184 · doi-reference
Cerebrospinal fluid cytology and clinical analysis of 34 cases with leptomeningeal carcinomatosis
10.1177/147323000903700629 · doi-reference
Neuraxis metastases of primary central nervous system tumors: A review of clinicopathological and radiographic characters of 198 cases in a single center
10.2147/cmar.s217672 · doi-reference
Leptomeningeal metastasis: Challenges in diagnosis and treatment
10.2174/157339411797642597 · doi-reference
Comparison of the diagnostic significance of cerebrospinal fluid metagenomic next-generation sequencing copy number variation analysis and cytology in leptomeningeal malignancy
10.1186/s12883-024-03655-7 · doi-reference
Brain metastases and leptomeningeal disease
10.1212/con.0000000000001354 · doi-reference
Contamination of cerebrospinal fluid by vertebral bone-marrow cells during lumbar puncture
10.1056/nejm198303243081206 · doi-reference
Diagnostic value of cerebrospinal fluid level of carcinoembryonic antigen in patients with leptomeningeal carcinomatous metastasis
10.3988/jcn.2010.6.1.33 · doi-reference
Leptomeningeal metastasis: Clinical experience of 519 cases
10.1016/j.ejca.2015.12.021 · doi-reference
Tumor marker test in cerebrospinal fluid for leptomeningeal metastasis diagnosis and response assessment in non-small-cell lung cancer
10.1111/ene.70245 · doi-reference